ISDA addresses Congress, New York Fed
on industry efforts
ISDA continues to take the lead in addressing regulatory questions around the OTC derivatives
industry. On June 9, CEO Robert Pickel testified in Washington before the US House of
Representatives Subcommittee on Capital Markets, Insurance, and Government Regulation
Committee on Financial Services.
[click here for more on this story]
European Accounting
Policy letter to IASB
ISDA’s accounting committee has a long
history of interaction with accounting
standard setters, in particular with the
IASB and the FASB. Regular committee
meetings provide ISDA members the
opportunity to anticipate some of the
contingent issues at stake in the work of
the IASB.
[click here for more on this story]
Three Criteria for Policy Reform
Last month, Treasury Secretary Timothy Geithner
announced a comprehensive regulatory reform proposal
for the OTC derivatives markets. The proposal is an
important step toward much-needed reform. We welcome
the recognition of industry measures to safeguard the
smooth functioning of our markets, and the need for the
continued availability of derivatives custom-tailored to
users’ needs.
[click here
for more on this story]
